[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ma et al., 2022 - Google Patents

Low-dose metformin targets the lysosomal AMPK pathway through PEN2

Ma et al., 2022

View HTML
Document ID
4008615762513046799
Author
Ma T
Tian X
Zhang B
Li M
Wang Y
Yang C
Wu J
Wei X
Qu Q
Yu Y
Long S
Feng J
Li C
Zhang C
Xie C
Wu Y
Xu Z
Chen J
Yu Y
Huang X
He Y
Yao L
Zhang L
Zhu M
Wang W
Wang Z
Zhang M
Bao Y
Jia W
Lin S
Ye Z
Piao H
Deng X
Zhang C
Lin S
Publication year
Publication venue
Nature

External Links

Snippet

Metformin, the most prescribed antidiabetic medicine, has shown other benefits such as anti- ageing and anticancer effects,,–. For clinical doses of metformin, AMP-activated protein kinase (AMPK) has a major role in its mechanism of action,; however, the direct molecular …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Similar Documents

Publication Publication Date Title
Ma et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2
Williams et al. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice
Hölscher et al. Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury
Oo et al. Engagement of S1P 1-degradative mechanisms leads to vascular leak in mice
Cortone et al. Interaction of the Warsaw breakage syndrome DNA helicase DDX11 with the replication fork-protection factor Timeless promotes sister chromatid cohesion
Zhang et al. The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK
Kotake et al. Role of serine 10 phosphorylation in p27 stabilization revealed by analysis of p27 knock-in mice harboring a serine 10 mutation
Gao et al. Mitochondria‐associated endoplasmic reticulum membranes (MAMs) and their prospective roles in kidney disease
Tseng et al. LMBD1 protein serves as a specific adaptor for insulin receptor internalization
Kern et al. A mitotic SKAP isoform regulates spindle positioning at astral microtubule plus ends
Nakayama et al. Interaction of ARRDC4 with GLUT1 mediates metabolic stress in the ischemic heart
Zhu et al. miR‐340‐5p mediates cardiomyocyte oxidative stress in diabetes‐induced cardiac dysfunction by targeting Mcl‐1
Yang et al. PHB2 ameliorates Doxorubicin-induced cardiomyopathy through interaction with NDUFV2 and restoration of mitochondrial complex I function
Yao et al. Upregulation of WDR6 drives hepatic de novo lipogenesis in insulin resistance in mice
Wagatsuma et al. Zinc transport via ZNT5-6 and ZNT7 is critical for cell surface glycosylphosphatidylinositol-anchored protein expression
US20100168014A1 (en) Screening method
Liu et al. SOCS3 negatively regulates cardiac hypertrophy via targeting GRP78-mediated ER stress during pressure overload
Xuan et al. Downregulation of Cypher induces apoptosis in cardiomyocytes via Akt/p38 MAPK signaling pathway
JPWO2008041665A1 (en) Method for screening for preventive and / or therapeutic drug for diseases associated with hepatitis C
Arimura et al. Overexpression of heart-specific small subunit of myosin light chain phosphatase results in heart failure and conduction disturbance
JP6854515B2 (en) Screening method for glycolytic metabolism regulators and glycolytic metabolism regulators
KR101002163B1 (en) Composition for preventing and treating an er-stress mediated disease comprising cyclophilin b
Mukherjee et al. Ube4A maintains metabolic homeostasis and facilitates insulin signaling in vivo
Zhao et al. DJ-1 activates the AMPK/mTOR pathway by binding RACK1 to induce autophagy and protect the myocardium from ischemia/hypoxia injury
Baldrighi et al. PLK1 inhibition dampens NLRP3 inflammasome–elicited response in inflammatory disease models